TNDM
Tandem Diabetes Care, Inc.
After-Market
16.90
Tandem Diabetes Care, Inc. Profile
About
Info & Links
CEO
John F. Sheridan
Headquarters
San Diego, CA 92130, UNITED STATES
Industry
Sector
Website
Auditor
Ernst & Young LLP
Share holders
38
Employees
2,500
Tandem Diabetes Care, Inc. Statistics
Valuation Measures
Market Capitalization2
1.18B
Enterprise Value
1.72B
Enterprise Value/EBITDA(ttm)
-58.30
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
1.13
Price to Book(mrq)
8.87
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
55.94%
Operating Margin(ttm)
-6.08%
Profit Margin(ttm)
-6.31%
Return on Equity(ttm)
-45.97%
Return on Invested Capital(ttm)
-10.57%
Return on Assets(ttm)
-6.23%
Income Statement
Revenue(ttm)
1.04B
Revenue Per Share(ttm)
14.97
Gross Profit(ttm)
583.32M
EBITDA(ttm)3
-29.43M
Net Income Available to Common(ttm)
-63.31M
Diluted EPS(ttm)
-0.93
Share Statistics
Beta (5Y Monthly)
1.55
52-Week Change
38.51%
S&P 500 52-Week Change
17.10%
S&P 500 Member
No
Stock Optionable
Yes
Total Shares Outstanding1
69.58M
Dividend Yield
0.00%
Float4
68.12M
% Held by Insiders
2.10%
% Held by Institutions
--
Balance Sheet
Total Cash(mrq)
456.00M
Total Cash Per Share(mrq)
6.55
Total Debt(mrq)
602.58M
Total Debt/Equity(mrq)
462.14%
Current Ratio(mrq)
3.18%
Quick Ratio(mrq)
2.65%
Book Value Per Share(mrq)
1.88
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.34
Free Cash Flow(ytd)
-33.89M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.